FP6Doctoral network2006–2010

CARBIO · Multi-functional carbon nanotubes for biomedical applications

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-10-01 → 2010-09-30
EU contribution
€3,050,500
Participants
8
Scheme
RTN

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

Final Activity Report Summary - CARBIO (Multi-functional carbon nanotubes for biomedical applications)

Nanotechnology has great potential to produce tiny devices smaller than a single cell that can be injected into the body to image tumours or even to seek out and kill cancer cells. In the CARBIO project we apply a broad multi-disciplinary approach ranging from basic research in chemistry, physics and biology to biophysical, biochemical and medical studies. We have focussed on the development of multi-functionalised carbon nanotubes that act as nanocontainers carrying drugs or imaging agents to target cells. These tiny nanodevices consist of shells of pure carbon which may be filled with drugs, metals or imaging agents. One of the key achievements of the project was to construct multifunctional nanotubes that can target cancer cells, deliver drugs to those cells or even act as antennae that absorb electromagnetic radiation and thereby deliver heat to destroy tumours from the inside. Background Carbon nanotubes are mechanically and chemically stable hollow carbon structures which can be functionalised both exohedrally and by filling with a tailored functional material. The carbon shells protect the biological environment and the filling material from each other. Degradation of filling materials is avoided and their potential toxicity and adverse effects are suppressed so that the CNT provides a smart carrier system on the nanometer scale. The CARBIO Network has: Synthesised CNTs with tailored functionalities and uniform morphology. Filled CNTs with tailored materials thereby forming packages in which the active content is encapsulated by a protecting carbon shell. Modified CNTs in order to render them long-term stably dispersed in aqueous solution and compatible to actual biological systems. Studied their uptake into and their fate within the single cell. Showed their feasibility for AC magnetic heating for hyperthermia anticancer treatment. Showed the feasibility for a contactless temperature control by virtue of NMR spectroscopy. Provided data on CNT toxicity and on their interaction with the immune system. Developed methods for drug-filling of CNT and for heat-induced drug-release of carbon nanostructures. Demonstrated that CNTs are both taken up but then released by cultured cells. Demonstrated that CNTs can be targeted to human cells. Demonstrated that CNTs can deliver active content to cultured cells: drugs, DNA, siRNA, cytotoxic drugs that are capable of killing cancer cells. Will generate ~100 scientific publications in international peer-reviewed journals, and a book (Carbon Nanotubes for Biomedical Applications, Springer 2010) summarising the achievements of the network. The envisaged applications of carbon nanotubes for therapy and diagnosis apply their potential for a targeted nanocontainer. The project has elucidated the usage of CNT for previously known applications and has also shown their feasibility for novel applications not encountered before. A particularly high potential is found when multiple functionalities are combined, e.g., drug transport, imaging and local heat generation. Particular emphasis has been put on the interaction of CNT with actual biological environments thereby providing valuable information on the interactions of this novel nanomaterial with living systems. The Network has developed a novel European research structure that has brought together young scientists from across the EU to work collaboratively towards the common aim of building safe and effective nanomedicine devices. The project has gained international visibility by providing training for scientists in leading European laboratories and has thereby become a paradigmatic example of training in experimental biomedical nanoscience. The Network's results allow better understanding and assessment of possible benefits and potential toxicological and environmental risks of nanomaterials which is a prerequisite for responsible application of nanotechnology. In this way, the Network not only promotes future research and technological applications but supports decision making and, eventually, responsible discussions on nanoscience in society.

Data: CORDIS, © European Union

Project objective

We will exploit the potential of multi-functional carbon nanotubes (CNT) for biomedical applications, in particular to act as magnetic nano-heaters, drug-carrier systems and sensors for diagnosis and therapy at a cellular level. CNT are hollow tubes (with 1, 2 or more walls) which can be filled with suitable materials and also be bio-functionalised, i.e. made compatible to biological environment. The long-term objective of the RTN is to develop and optimise multi-functional CNT for human medical applications with a focus on anti-tumour therapy " which allow targeted release of heat or drugs in diseased cells. For this aim, combined multidisciplinary efforts are necessary ranging from the synthesis, thorough investigation and biofunctionalisation of CNT to studies of their interaction (toxicity, biocompatibility) with biological environments and their diagnostic/therapeutic usability. Hence, a broad multidisciplinary approach in the crossover between physics, chemistry, biology, biochemistry, biophysics, engineering and medicine has to be applied and a new generation of scientists has to be trained. We will do this by addressing 11 strongly interacting work packages which cover all aspects of experimental biomedical nanoscience on the basis of targeted research on multi-functional CNT. Additional local and network-wide training activities, training in complementary skills dedicated to research in biomedical nanoscience (ethical and safety aspects, patents etc.), and the cooperation with industrial partners will guarantee the complete education in this innovative field of applied science. The RTN addresses major objectives of FP6 by combatting a global disease whilst involving nanobiotechnology and creating a new multidisciplinary training structure. The possible application of CNT in tumour therapy highlights the fact that by addressing the combat of a major global disease basic research can find direct applications concerning wider parts of society."

Original text from CORDIS.

Participants

  • LEIBNIZ-INSTITUT FUER FESTKOERPER- UND WERKSTOFFFORSCHUNG DRESDEN E.V. · DRESDENCoordinatorCity levelGermany
  • JOHANNES KEPLER UNIVERSITAET LINZ · LINZAustria
  • TECHNISCHE UNIVERSITAET DRESDEN · DRESDENGermany
  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OXFORDUnited Kingdom
  • UNIVERSITE PAUL SABATIER-TOULOUSE III · TOULOUSEFrance
  • UNIVERSITEIT TWENTE · ENSCHEDENetherlands
  • UNIVERSITY OF SURREY · GUILDFORDUnited Kingdom
  • ZACHODNIOPOMORSKI UNIWERSYTET TECHNOLOGICZNY · SZCZECINPoland

Links

Data: CORDIS, © European Union